The T_T genotype within the NME1 promoter single nucleotide polymorphism −835 C/T is associated with an increased risk of cytarabine induced neurotoxicity in patients with acute myeloid leukemia

Dominic BraunagelDivision of Immunotherapy and Gene Therapy, Department of Internal Medicine, Saarland University Medical Center, José Carreras Research Center, Homburg/Saar, Germany

Markus SchaichDepartment of Internal Medicine, University of Dresden, Dresden, Germany

Michael KramerDepartment of Internal Medicine, University of Dresden, Dresden, Germany

Christian-Lars DransfeldDivision of Immunotherapy and Gene Therapy, Department of Internal Medicine, Saarland University Medical Center, José Carreras Research Center, Homburg/Saar, Germany

Gerhard EhningerDepartment of Internal Medicine, University of Dresden, Dresden, Germany

Ulrich MahlknechtDivision of Immunotherapy and Gene Therapy, Department of Internal Medicine, Saarland University Medical Center, José Carreras Research Center, Homburg/Saar, GermanyCorrespondence[email protected]

The T_T genotype within the NME1 promoter single nucleotide polymorphism −835 C/T is associated with an increased risk of cytarabine induced neurotoxicity in patients with acute myeloid leukemia

Data relating to positions of SNPs

Data relating to positions of SNPs

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

The T_T genotype within the NME1 promoter single nucleotide polymorphism −835 C/T is associated with an increased risk of cytarabine induced neurotoxicity in patients with acute myeloid leukemia

Data relating to positions of SNPs

Data relating to positions of SNPs

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date